v3.22.2.2
Earnings per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The calculation of basic and diluted earnings per share for the three and nine months ended September 30, 2022 and 2021, was as follows (in thousands, except share and per share amounts):
 For the three months ended September 30,
For the nine months ended September 30,
 2022202120222021
Net loss attributable to common stockholders - basic and diluted(96,980)(1,055)(12,446)(1,282)
Class A Common Stock
Weighted average shares of common stock outstanding - basic(1)
154,455,228 88,741,089 153,482,503 88,741,089 
Weighted average shares of common stock outstanding - diluted(1)(2)(3)
154,455,228 88,741,089 153,482,503 88,741,089 
Net loss attributable to common stockholders per share - basic and diluted$(0.63)$(0.01)$(0.08)$(0.01)

(1) The calculation of basic weighted average shares of common stock outstanding excludes 542,511 shares of the Company's Class A common stock provided to holders of Legacy Altus common stock, including shares that were subject to vesting conditions (the "Altus Restricted Shares") for the three and nine months ended September 30, 2022, and 1,259,887 shares of Company Class A common stock provided to holders of Altus Restricted Shares for the three and nine months ended September 30, 2021. The calculation of diluted weighted average shares of common stock for the three and nine months ended September 30, 2022, and 2021, also excludes these shares because their inclusion would have had an anti-dilutive effect.
(2) Excludes 4,182,730 Redeemable Warrants for the three and nine months ended September 30, 2022. The Redeemable Warrants are exercisable at $11.00 per share. As the warrants are deemed anti-dilutive, they are excluded from the calculation of earnings per share.
(3) Excludes 2,323,574 shares of the Company's Class A common stock provided to holders of restricted stock units granted under the Omnibus Incentive Plan for the three and nine months ended September 30, 2022, because their inclusion would have had an anti-dilutive effect.